|4Feb 3, 8:07 PM ET

BONNER EIMEAR P 4

4 · CHEVRON CORP · Filed Feb 3, 2026

Research Summary

AI-generated summary of this filing

Updated

Chevron (CVX) CFO Eimear Bonner Exercises Options, Sells Shares

What Happened

  • Eimear P. Bonner, Chevron’s Chief Financial Officer, exercised stock options and sold shares in transactions reported Jan 30–Feb 1, 2026. On Jan 30 she exercised 32,100 option shares at $132.69 (cost ~$4.26M) and sold those 32,100 shares in the open market at a weighted‑average price of $175.01 for proceeds of ~$5.62M. On Jan 31 certain restricted‑stock units/derivative awards vested or converted and were settled (including a cash settlement to the issuer and shares withheld for taxes). A new award of 14,400 restricted stock units was reported as granted on Feb 1, 2026.

Key Details

  • Transaction dates/prices:
    • 2026‑01‑30: Exercised 32,100 options at $132.69 (acquired for ~$4.26M); sold 32,100 shares in open market at weighted‑avg $175.01 (proceeds ~$5.62M). Sale executed under a Rule 10b5‑1 plan; trade prices ranged $175.00–$175.03.
    • 2026‑01‑31: Converted/settled 7,001 RSU‑equivalent shares and disposed to the issuer for $176.90/share (cash settlement ≈ $1.24M). Also 1,679 shares converted and 661 shares were surrendered/withheld at $176.90 to cover tax liability (tax withholding ≈ $116,931).
    • 2026‑02‑01: Report of grant/award of 14,400 restricted stock units (no cash cost at grant).
  • Shares owned after the reported transactions: not specified in the filing.
  • Notable footnotes:
    • Sales on Jan 30 executed pursuant to a Rule 10b5‑1 trading plan (F1).
    • Sale price reported is a weighted average of multiple trades (F2).
    • Several items are restricted stock units or derivative conversions; some RSUs were payable in cash upon vesting (F3–F6, F7–F8).
    • Option exercised was granted Jan 26, 2022 with customary vesting schedule (F4).
  • Filing timeliness: Form 4 was filed Feb 3, 2026 for transactions dated Jan 30–Feb 1, 2026; the filing appears to be within the SEC’s short reporting window for these transactions.

Context

  • This was largely a cashless exercise: options were exercised and the resulting shares were sold the same day (common for executives to cover exercise cost and taxes). The January 31 entries reflect RSU vesting and cash/share settlement plus withholding for taxes (not a market purchase). The Feb 1 entry is a new RSU grant that will vest in future years per the footnotes.
  • These transactions are routine compensation‑related activity (exercises, RSU vesting, and tax withholding) rather than an outright directional purchase of additional stock.

Insider Transaction Report

Form 4
Period: 2026-01-30
BONNER EIMEAR P
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-01-30$132.69/sh+32,100$4,259,34936,466 total
  • Sale

    Common Stock

    [F1][F2]
    2026-01-30$175.01/sh32,100$5,617,7314,366 total
  • Exercise/Conversion

    Common Stock

    [F3]
    2026-01-31+7,00111,367 total
  • Disposition to Issuer

    Common Stock

    2026-01-31$176.90/sh7,001$1,238,4774,366 total
  • Exercise/Conversion

    Common Stock

    [F3]
    2026-01-31+1,6796,045 total
  • Tax Payment

    Common Stock

    2026-01-31$176.90/sh661$116,9315,384 total
  • Exercise/Conversion

    Non-Qualified Stock Option (Right to Buy)

    [F4]
    2026-01-3032,1000 total
    Exercise: $132.69Exp: 2032-01-26Common Stock (32,100 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F3][F5]
    2026-01-317,0010 total
    Exercise: $0.00Common Stock (7,001 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F3][F6][F7]
    2026-01-311,6790 total
    Exercise: $0.00Common Stock (1,679 underlying)
  • Award

    Restricted Stock Units

    [F3][F8]
    2026-02-01+14,40014,400 total
    Exercise: $0.00Common Stock (14,400 underlying)
Holdings
  • Common Stock

    (indirect: Share Incentive Plan)
    408
Footnotes (8)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2025.
  • [F2]This transaction was executed in multiple trades at prices ranging from $175.00 to $175.03. The price reported above reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range provided.
  • [F3]Each restricted stock unit is the economic equivalent of one share of Chevron common stock.
  • [F4]Option granted January 26, 2022. One-third of the shares subject to the option vested on January 31, 2023, January 31, 2024 and January 31, 2025, respectively.
  • [F5]Restricted stock units accrue dividend equivalents in the form of additional restricted stock units. The restricted stock units are payable in cash and vested on January 31, 2026.
  • [F6]This number includes dividend equivalents (74 shares).
  • [F7]Restricted stock units granted on January 25, 2023 under the Chevron Corporation 2022 Long-Term Incentive Plan. Restricted stock units accrue dividend equivalents in the form of additional restricted stock units. One-third of the shares vested on January 31, 2024, January 31, 2025 and January 31, 2026, respectively, and settled in shares of Chevron common stock on the date of vesting. Shares issued upon vesting are subject to a two-year post-vesting holding period, which is removed upon termination of employment.
  • [F8]Restricted stock units granted under the Chevron Corporation 2022 Long-Term Incentive Plan. Restricted stock units accrue dividend equivalents in the form of additional restricted stock units. One-third of the shares subject to this award will vest on February 1, 2027, February 1, 2028 and February 1, 2029, respectively, and will settle in shares of Chevron common stock on the date of vesting. Shares issued upon vesting are subject to a two-year post-vesting holding period, which is removed upon termination of employment.
Signature
/s/ Rose Z. Pierson, Attorney-in-Fact for Eimear P. Bonner|2026-02-03

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT